Relating to newborn screening tests for Duchenne muscular dystrophy.

HB 2295 requires Texas hospitals and physicians to screen all newborns for Duchenne muscular dystrophy (DMD) using approved tests, alongside existing screenings for conditions like phenylketonuria and hypothyroidism. The bill amends health code provisions to mandate this screening under Section 33.011 and requires the health department to notify parents or healthcare providers if results indicate potential DMD. It also expands the department's role in developing screening methods and maintaining labs for early detection of DMD and other heritable disorders. This policy directly affects all newborns in Texas and the healthcare providers responsible for their initial care.